Phase 1/2a First-In-Human Study of BMS-986207 Monoclonal Antibody Alone and in Combination with Nivolumab in Advanced Solid Tumors June 15, 2017 Sponsor Bristol-Myers Squibb Protocol Number Bristol Myers Squibb CA020-002 To Learn More Call 201-510-0910
